Middle East & Africa Biomarker Testing Services Market Size & Outlook
Related Markets
MEA biomarker testing services market highlights
- The MEA biomarker testing services market generated a revenue of USD 29.9 million in 2024.
- The market is expected to grow at a CAGR of 7.8% from 2025 to 2030.
- In terms of segment, oncology was the largest revenue generating services in 2024.
- Oncology is the most lucrative services segment registering the fastest growth during the forecast period.
- Country-wise, Israel is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 29.9 million |
| Market revenue in 2030 | USD 46.5 million |
| Growth rate | 7.8% (CAGR from 2025 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Oncology |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug discovery & development, Oncology |
| Key market players worldwide | Eurofins Scientific SE, SGS AG, Charles River Laboratories International Inc, Labcorp Drug Development, Thermo Fisher Scientific Inc, Icon PLC, IQVIA Holdings Inc, Syneos Health, Intertek Group PLC, BioAgilytix Labs |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.6% of the global biomarker testing services market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 162.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biomarker Testing Services Market Scope
Biomarker Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioAgilytix Labs | View profile | 501-1000 | Durham, North Carolina, United States, North America | http://www.bioagilytix.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| SGS AG | View profile | 103193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | https://www.sgs.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Middle East & Africa biomarker testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomarker testing services market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 55.52% in 2024. Horizon Databook has segmented the Middle East & Africa biomarker testing services market based on drug discovery & development, oncology covering the revenue growth of each sub-segment from 2018 to 2030.
The biomarker testing services market in the MEA region will likely grow steadily in the coming years. Increasing privatization is the major factor contributing to the growth of the market. Moreover, increasing investment initiatives by the government to improve the region's healthcare system is also one factor driving the market growth.
However, the country's underdeveloped health infrastructure may hamper market growth in the forecasted period. For instance, the WHO International Clinical Trials Registry Platform (ICTRP) reports 861 clinical trials registered in Africa in 2022.
Moreover, less competition between pharmaceutical companies in underdeveloped countries of the region is encouraging various pharmaceutical startups in the region and thereby results in regional market growth.
Reasons to subscribe to Middle East & Africa biomarker testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa biomarker testing services market databook
-
Our clientele includes a mix of biomarker testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa biomarker testing services market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa biomarker testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA biomarker testing services market size, by country, 2018-2030 (US$M)
Middle East & Africa Biomarker Testing Services Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
